For example, in an experimental model of CCl4-induced liver disease, the administration of Silymarin-conjugated gold nanoparticles reduced the proportion of α-SMA immunoreactive cells and the amount of collagen in liver tissue in comparison with the positive control group [51]. Here, ACTA1 is linked to liver disorder.